Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytomegalovirus Viremia”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Testing effectiveness (Phase 2)Study completedNCT01911546
What this trial is testing

Role of Everolimus in Highly Sensitized Patients

Who this might be right for
Highly-sensitized Kidney Transplant Recipients
Joseph Kahwaji, MD, MPH 20
Post-approval studies (Phase 4)Study completedNCT00431353
What this trial is testing

VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients

Who this might be right for
Cytomegalovirus Infections
Hoffmann-La Roche 325
Not applicableUnknownNCT04298502
What this trial is testing

The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human

Who this might be right for
Acute LeukemiaCMV ViremiaHematopoietic Stem Cell Transplantation
Peking University People's Hospital 40
Not applicableUnknownNCT00004573
What this trial is testing

Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative Real-Time PCR

Who this might be right for
Cytomegalovirus Infections
National Center for Research Resources (NCRR)
Not applicableLooking for participantsNCT06341543
What this trial is testing

Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)

Who this might be right for
Cytomegalovirus InfectionsHeart TransplantationKidney Transplantation+2 more
University Hospital, Grenoble 288
Testing effectiveness (Phase 2)Study completedNCT01646645
What this trial is testing

Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegalovirus
Memorial Sloan Kettering Cancer Center 58
Early research (Phase 1)Study completedNCT00002268
What this trial is testing

A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Sandoz
Not applicableEnrolling By InvitationNCT06263218
What this trial is testing

Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil

Who this might be right for
CMV InfectionCMV Viremia
Hospital do Rim e Hipertensão 500
Not applicableLooking for participantsNCT06339892
What this trial is testing

HCMV Breakthrough Infections During Letermovir Prophylaxis

Who this might be right for
Cytomegalovirus InfectionsCytomegalovirus ViremiaHematopoietic Stem Cell Transplantation
Fondazione IRCCS Policlinico San Matteo di Pavia 140
Not applicableStudy completedNCT02784756
What this trial is testing

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

Who this might be right for
Cytomegalovirus Viraemia
University Health Network, Toronto 134
Testing effectiveness (Phase 2)Looking for participantsNCT06059391
What this trial is testing

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
City of Hope Medical Center 216
Early research (Phase 1)Looking for participantsNCT06011486
What this trial is testing

Expansion of Virus-Specific Lymphocytes for Cell Therapy

Who this might be right for
CMV ViremiaCMV
Hospital Israelita Albert Einstein 10
Testing effectiveness (Phase 2)Study completedNCT04018261
What this trial is testing

Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients

Who this might be right for
CMV ViremiaImmunosuppression-related Infectious Disease
Banc de Sang i Teixits 26
Large-scale testing (Phase 3)Not Yet RecruitingNCT07225972
What this trial is testing

Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone

Who this might be right for
CMVAdV InfectionAdV Reactivation+2 more
New York Medical College 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06971913
What this trial is testing

Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia

Who this might be right for
SLE (Systemic Lupus)CMV
Peking University People's Hospital 100
Post-approval studies (Phase 4)Study completedNCT00947141
What this trial is testing

Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)

Who this might be right for
Viraemia
University College, London 165
Large-scale testing (Phase 3)Study completedNCT00006145
What this trial is testing

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 350
Testing effectiveness (Phase 2)Study completedNCT01329185
What this trial is testing

Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients

Who this might be right for
EBV ViremiaCMV Viremia
University of Minnesota 17
Early research (Phase 1)Not Yet RecruitingNCT07020533
What this trial is testing

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more
City of Hope Medical Center 46
Not applicableUnknownNCT03858907
What this trial is testing

Cytomegalovirus Risk in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMV

Who this might be right for
Cytomegalovirus InfectionsCMVKidney Transplant Infection
University of Sao Paulo General Hospital 180
Load More Results